Are you ready for the SonoSite Experience?
If remarkable image quality, low cost, easy to use, portable ultrasound technology is important to you, then maybe you are.
Reduce risks, Increase efficiency. Reduce costs.
SonoSite is the world’s leader in portable ultrasound equipment, that is hand-held and mountable. Sonosite is also the leader in impedance cardiograph equipment. When you want to focus on the patient and not the technology, SonoSite portable ultrasound machines are just what you are looking for.
SonoSite has more than business and cutting edge technology in mind. They created the hand-held ultrasound machine in part to go to people who wouldn’t normally or quickly be able to visit a hospital or doctor because of remote location, social conditions, or poverty. As well, it is designed for home visits, EMT’s, sports medicine, as well as hospitals.
The hand-held ultrasound technology by SonoSite is lightweight (around 7lbs), and turns on within 15 seconds so you can begin to immediately diagnose your patient and begin to set a plan of action for recovery or resumption of life. This speed of service saves hours of time from having to go get an MRI or CT and wait for the results. Now, within minutes, a medical professional can view the musculoskeletal structure non-invasively and see if any damage has been done. The patient is comforted as well as they can see from the monitor what is happening in their body and be certain the diagnosis is accurate.
What’s more, the SonoSite portable ultrasound equipment allows for movement of the joint area to occur in the assessment stage assuring a more comprehensive view into the patients injury, while with MRI’s one has to be perfectly still to get the image.
SonoSite hand-held ultrasound systems are also radiation-free, unlike MRI’s and CT’s
Recent studies have shown that employing diagnostic ultrasound instead of CT’s and MRI’s saves everyone involved money. Had a diagnostic ultrasound machine been used first instead of an MRI for ankle injuries rotator cuffs in 2009 alone, our system would’ve saved over $90 million dollars, according to KNG Health Consulting, LLC. Now, imagine the savings to Medicaid, patients, and others had diagnostic ultrasound been used for those with possible heart disease, knee problems, colon issues, and the many more applications the hand-help SonoSite ultrasound machine could be used for as a first responder or physician tool? In 2008, Parker et al., said that over $6.9 billion would have been saved had ultrasound been used first instead of MRI’s and CT’s. This savings is impressive. Utilizing SonoSite’s miniaturized ultrasound machines to meet patients at the door could save more than money, but save lives as well.
Another challenge in the past for doctors has been the use of needles in treatment. Needles have been a challenge in the past for ultrasound systems, but not anymore, especially with SonoSite’s new software. Now there are simple techniques to have needles magically appear, as SonoSite delivers exceptional visualization of needles from entry down into the structure one is trying to see. No special needles are needed. There is immediate improvement in accuracy and less pain in patient as you are able to target structure much more accurately making it less painful for the patient. This comes from more than just a tweak in the SonoSite software, but a major improvement that has led to this industry changing technology.
Imaging Associates carries portable ultrasound equipment from Sonosite in our used ultrasound equipment, and refurbished ultrasound equipment category and we are a certified Sonosite dealer in new ultrasound systems and we are an ISO 9000 certified services contractor as well.
Sonosite portable ultrasound machines Imaging Associates carries and services
M-Turbo - High Resolution Imaging Across the Point of Care
SonoSites most versatile system for abdominal, nerve, vascular, cardiac, venous access, pelvic, and superficial imaging. The M-Turbo® ultrasound system gives you striking image quality with sharp contrast resolution and clear tissue delineation. This ultrasound equipment lets you visualize detail, improving your ability to differentiate structures, vessels and pathology.
MicroMaxx – A Proven Performer
Designed to make your job easier, faster and more accurate, the MicroMaxx® ultrasound system makes point-of-care ultrasound an affordable reality. It offers impressive image quality, wireless data transfer, and extreme durability. From busy offices and big-city hospitals to critical-care situations where seconds count, the MicroMaxx ultrasound equipment boots up within 15 seconds. This portable ultrasound gets medical professionals into—and out of—tight spaces fast. The MicroMaxx system software is hard-wired and purpose-built for faster boot-up times, faster digital image processing, and the ability to run for a long time. Power is efficiently used, extending battery life for use
1. United States. 2001. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Evidence report/technology assessment, no. 43. Rockville, Md: Agency for Healthcare Research and Quality.
a. Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM. Complications and failures of subclavian-vein catheterization. N Engl J Med.1994;331:1735-1738.
b. Sznajder JI, Zveibil FR, Bitterman H, Weiner P, Bursztein S. Central vein catheterization. Failure and complication rates by three percutaneous approaches. Arch Intern Med. 1986;146:259-261.
c. Bernard RW, Stahl WM. Subclavian vein catheterizations: a prospective study. I. Non-infectious complications. Ann Surg. 1971;173:184-190.
2. MedPAR data from the Centers for Medicare and Medicaid Services (CMS), analyzed by KNG Consulting.
a. Iatrogenic Pneumothorax (ICD-9 512.1) was reported in 29,691 of 12,866,082 total Medicare discharges in 2007. Infection due to central venous catheter (ICD-9 999.31) was reported in 24,420 of 11,855,943 total Medicare discharges in 2008.
3. Raptopoulos V, LM Davis, G Lee, C Umali, R Lew, and RS Irwin. 1991. Factors affecting the development of pneumothorax associated with thoracentesis.AJR. 156 (5): 917-20.
4. Zhan C, M Smith, and D Stryer. Incidences, Outcomes and Factors Associated with Iatrogenic Pneumothorax in Hospitalized Patients [abstract]. In: AcademyHealth Annual Research Meeting.; 2004; San Diego, Calif. Academy Health. 2004; 21: abstract no. 1862.
- “Depending on age and comorbidities, iatrogenic pneumothorax was associated with 4 to 7 excess days in length of stay, between $17,000 and $45,000 in excess charges, and 1% to 14% in excess mortality.”